Cidara Therapeutics
Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push
Merck; Cidara Therapeutics; CD388; antiviral; acquisition; influenza; phase 3; FDA Breakthrough Therapy; J&J; Sanofi; Keytruda
Actionable Insights Powered by AI
Merck; Cidara Therapeutics; CD388; antiviral; acquisition; influenza; phase 3; FDA Breakthrough Therapy; J&J; Sanofi; Keytruda